This study will collect data that measures the effects of a psychedelic intervention on patients struggling with alcohol use disorder (AUD). The study design will be a double blind, randomized, active-comparator trial with two study arms. Subjects randomized to Arm 1 (n=40) will receive individual psychotherapy sessions plus a 30 mg dose of psilocybin. Arm 2 subjects (n=40) will receive individual psychotherapy sessions and a 0.75 mg/kg dose of ketamine.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
80
30 mg single dose
0.75 mg/kg weight-based single dose
University of Iowa Health Care
Iowa City, Iowa, United States
RECRUITINGTimeline Follow-Back for Alcohol to assess change
Quantifies daily alcohol use
Time frame: Weekly, over the course of 16 weeks
T1rho
Measures biological changes in the brain
Time frame: Twice (before intervention, post intervention): at week 1 and week 16
Resting state fMRI
Measures biological changes in brain resting state global functional connectivity
Time frame: Twice (before intervention, post intervention):: at week 1 and week 16
EEG- signal complexity
Measures electrical signal change
Time frame: Twice (before drug administration and at peak of drug experience) during week 3
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.